The peripheral differentiation of human natural killer T cells.


Journal

Immunology and cell biology
ISSN: 1440-1711
Titre abrégé: Immunol Cell Biol
Pays: United States
ID NLM: 8706300

Informations de publication

Date de publication:
07 2019
Historique:
received: 04 05 2017
revised: 07 06 2017
accepted: 11 03 2019
pubmed: 16 3 2019
medline: 4 4 2020
entrez: 16 3 2019
Statut: ppublish

Résumé

The peripheral maturation of human CD1d-restricted natural killer T (NKT) cells has not been well described. In this study, we identified four major subsets of NKT cells in adults, distinguished by the expression of CD4, CD8 and CCR5. Phenotypic analysis suggested a hierarchical pattern of differentiation, whereby immature CD4

Identifiants

pubmed: 30875134
doi: 10.1111/imcb.12248
pmc: PMC6767057
doi:

Substances chimiques

Antigens, CD1d 0
CCR5 protein, human 0
CD4 Antigens 0
CD8 Antigens 0
Cytokines 0
Receptors, Antigen, T-Cell 0
Receptors, CCR5 0

Types de publication

Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

586-596

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

© 2019 The Authors. Immunology & Cell Biology published by John Wiley & Sons Australia, Ltd on behalf of Australasian Society for Immunology Inc.

Références

J Exp Med. 2002 Mar 4;195(5):625-36
pubmed: 11877485
PLoS One. 2011;6(12):e28648
pubmed: 22174854
J Exp Med. 2005 Aug 15;202(4):485-92
pubmed: 16087715
Proc Natl Acad Sci U S A. 2004 May 4;101(18):7058-63
pubmed: 15118099
J Immunol. 2003 Dec 1;171(11):5913-20
pubmed: 14634102
J Immunol. 2017 Jul 1;199(1):159-171
pubmed: 28576977
Clin Exp Immunol. 2013 Apr;172(1):129-37
pubmed: 23480193
J Immunol. 2003 Sep 1;171(5):2571-80
pubmed: 12928408
J Immunol. 2002 Mar 15;168(6):3099-104
pubmed: 11884484
J Exp Med. 2000 Sep 4;192(5):741-54
pubmed: 10974039
Immunity. 2015 Sep 15;43(3):566-78
pubmed: 26362265
Blood. 2002 Jul 1;100(1):11-6
pubmed: 12070001
Blood. 2004 Dec 15;104(13):4150-6
pubmed: 15328159
Eur J Immunol. 2005 May;35(5):1399-407
pubmed: 15816002
Nature. 1998 Dec 17;396(6712):690-5
pubmed: 9872319
Nat Immunol. 2010 Mar;11(3):197-206
pubmed: 20139988
J Exp Med. 1993 Jul 1;178(1):1-16
pubmed: 8391057
J Allergy Clin Immunol. 2014 Apr;133(4):1109-15
pubmed: 24406074
Nat Rev Immunol. 2012 Dec;12(12):845-57
pubmed: 23154222
Nat Rev Immunol. 2013 Feb;13(2):101-17
pubmed: 23334244
PLoS One. 2011 Jan 31;6(1):e15714
pubmed: 21305060
Immunol Today. 1999 May;20(5):212-6
pubmed: 10322299
J Exp Med. 2002 Mar 4;195(5):637-41
pubmed: 11877486
Proc Natl Acad Sci U S A. 2016 Jul 5;113(27):7602-7
pubmed: 27325774
Nat Rev Immunol. 2014 Sep;14(9):640-6
pubmed: 25103356
Science. 2002 Apr 19;296(5567):553-5
pubmed: 11968185
Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3294-8
pubmed: 11248072
Nucleic Acids Res. 1999 Jan 1;27(1):209-12
pubmed: 9847182
Curr Protoc Immunol. 2011 Aug;Chapter 10:Unit10.33
pubmed: 21809317
J Immunol Methods. 2004 Feb 15;285(2):197-214
pubmed: 14980434
Nat Rev Immunol. 2004 Mar;4(3):231-7
pubmed: 15039760
J Exp Med. 2005 Dec 19;202(12):1623-6
pubmed: 16365145
Nat Med. 2011 Sep 18;17(10):1290-7
pubmed: 21926977
Cell. 2018 Jan 25;172(3):517-533.e20
pubmed: 29249358
Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12636-41
pubmed: 11592984
J Exp Med. 2005 Nov 21;202(10):1349-61
pubmed: 16287711
Immunobiology. 2013 Feb;218(2):213-24
pubmed: 22647874
J Exp Med. 1994 Sep 1;180(3):1097-106
pubmed: 7520467
J Exp Med. 1994 Sep 1;180(3):1171-6
pubmed: 8064234
J Exp Med. 2002 Apr 1;195(7):835-44
pubmed: 11927628
J Immunol. 2013 Aug 15;191(4):1666-76
pubmed: 23851681
Immunology. 2007 Sep;122(1):1-14
pubmed: 17662044
Nat Rev Immunol. 2004 Aug;4(8):648-55
pubmed: 15286731
Nat Immunol. 2015 May;16(5):517-24
pubmed: 25848867

Auteurs

Jie Liu (J)

Laboratory of Infectious Diseases and Vaccines, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, PR China.
ImmunoTechnology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.

Brenna J Hill (BJ)

Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.

Sam Darko (S)

Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.

Kaimei Song (K)

ImmunoTechnology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.

Máire F Quigley (MF)

Division of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff, CF14 4XN, UK.

Tedi E Asher (TE)

Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.

Yohei Morita (Y)

Leibniz Institute on Aging, Fritz Lipmann Institute, 07745, Jena, Germany.

Hui Y Greenaway (HY)

Infection Analytics Program, Kirby Institute for Infection and Immunity, University of New South Wales Sydney, Sydney, NSW, 2052, Australia.

Vanessa Venturi (V)

Infection Analytics Program, Kirby Institute for Infection and Immunity, University of New South Wales Sydney, Sydney, NSW, 2052, Australia.

Daniel C Douek (DC)

Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.

Miles P Davenport (MP)

Infection Analytics Program, Kirby Institute for Infection and Immunity, University of New South Wales Sydney, Sydney, NSW, 2052, Australia.

David A Price (DA)

Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.
Division of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff, CF14 4XN, UK.

Mario Roederer (M)

ImmunoTechnology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH